DiscoverAt the Intersection of Science and LawUnderstanding AI and its use in drug discovery
Understanding AI and its use in drug discovery

Understanding AI and its use in drug discovery

Update: 2021-10-05
Share

Description

DLA Piper partners Ellen Scordino and Susan Krumplitsch are joined by Duane Valz, General Counsel of Insitro, to discuss how machine learning is being used to generate and leverage data for the development of better medicines.

See omnystudio.com/listener for privacy information.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Understanding AI and its use in drug discovery

Understanding AI and its use in drug discovery

DLA Piper